The Food and Drug Administration has recalled another blood pressure medication for detecting trace amounts of N-nitrosodiethylamine (NDEA).
Losartan Potassium Tablets from Torrent Pharmaceuticals Limited, USP; Losartan Potassium and Hydrochlorothiazide Tablets (USP) are the products the company has recalled because of trace levels of the cancer-causing chemical in the drug.
This is the third blood pressure medication that has been available since the beginning of 2019. At the end of 2018, other blood pressure medicines were recalled.
Blood pressure medicines recalled since November 2018 include: Prinston Pharmaceutical Inc. Detection of a trace amount of unexpected contamination, N-nitrosodiethylamine (NDEA); Aurobinda (Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP), Mylan (Valsartan-containing Products), Teva Pharmaceuticals (Amlodipine / Valsartan Combination Tables and Amlopidine / Valsartan / Hydrochloride Azide Combiner) Valsartan Tablets ; Valsartan and hydrochlorothiazide tablets), Torrent Pharmaceuticals Limited (Losartan Potassium Tablets, USP).
More information about the FDA can be found here.